BNTC icon

Benitec Biopharma

17 hedge funds and large institutions have $5.57M invested in Benitec Biopharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SCM
1
Suvretta Capital Management
New York
$3.12M 769,000
Franklin Resources
2
Franklin Resources
California
$2.39M 10,000,000
Vanguard Group
3
Vanguard Group
Pennsylvania
$17.8K 74,773
VF
4
Virtu Financial
New York
$13K 52,869 -68,645 -56%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$11.5K 48,223
Morgan Stanley
6
Morgan Stanley
New York
$9.21K 38,600 -6,900 -15%
State Street
7
State Street
Massachusetts
$5.11K 21,438
PAG
8
Private Advisor Group
New Jersey
$3.14K 13,157
WA
9
WealthTrust Axiom
Pennsylvania
$3.09K 12,950
Northern Trust
10
Northern Trust
Illinois
$2.82K 11,813
TRCT
11
Tower Research Capital (TRC)
New York
$1.78K 7,465 -96 -1%
RhumbLine Advisers
12
RhumbLine Advisers
Massachusetts
$752 3,161 +3,161 New
Group One Trading
13
Group One Trading
Illinois
$358 1,500
MHR
14
Matthew Hamilton Rosenberg
$91 381
UBS Group
15
UBS Group
Switzerland
$82 347
Wells Fargo
16
Wells Fargo
California
$48 202 +9 +5%
Renaissance Technologies
17
Renaissance Technologies
New York
-224,879 Closed
Walleye Capital
18
Walleye Capital
New York
-215,989 Closed
Two Sigma Investments
19
Two Sigma Investments
New York
-26,747 Closed
CF
20
Cantor Fitzgerald
New York
-25,050 Closed
CAN
21
Cetera Advisor Networks
California
-12,351 Closed
CG
22
Cutler Group
California
$0 1,000
Simplex Trading
23
Simplex Trading
Illinois
CFGS
24
Concourse Financial Group Securities
Alabama